The risk of developing long COVID has decreased significantly over the course of the COVID-19 pandemic, according to an analysis of data led by Washington University School of Medicine in St. Louis.
Jul 17, 2024
0
94
One of the many challenges over the course of the past two years has been in understanding the importance of the different routes of transmission of the SARS-CoV-2 virus that causes COVID. Understanding the role of the different ...
Feb 7, 2022
0
6
A simple RNA molecule jumpstarts the immune system's "first responders" to viral infection and can even eradicate the SARS-CoV-2 virus in mice with chronic cases of COVID-19, a new Yale School of Medicine study finds.
Nov 10, 2021
0
8
National Institutes of Health scientists studying SARS-CoV-2, the virus that causes COVID-19, have defined in Syrian hamsters how different routes of virus exposure are linked to disease severity. Their study, published ...
Aug 17, 2021
0
767
COVID-19 vaccines may provide protection for at least a year, and possibly even a lifetime, to people who were previously exposed to the virus, two new studies suggest.
May 28, 2021
0
3
Mayo Clinic experts say that regardless of the variant, prevention of infection works. The vaccines reduce and prevent hospitalization and death based on current knowledge. If a person can get vaccinated or is eligible for ...
Dec 9, 2021
0
25
As the COVID-19 pandemic continues to spread across the world, killing thousands and bringing economies to their knees, doctors, scientists and governments are on the lookout for safe and effective treatments to help those ...
Apr 16, 2020
0
4
Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics. The first volunteer is expected to receive ...
Dec 14, 2021
0
15
A study by University of Nebraska Medical Center researchers provides new evidence of infectious SARS-CoV-2 throughout the environment and in air samples collected in COVID-19 patient care areas. SARS-CoV-2 is the virus that ...
Aug 6, 2020
0
4
MUSC Hollings Cancer Center oncologists found that using a combination monoclonal antibody (tixagevimab-cilgavimab) against the SARS-CoV-2 spike protein in patients with blood cancers prevented moderate and severe COVID cases. ...
Dec 16, 2022
0
18
